Effect of the implantable atrial defibrillator on the natural history of atrial fibrillation

Citation
Hf. Tse et al., Effect of the implantable atrial defibrillator on the natural history of atrial fibrillation, J CARD ELEC, 10(9), 1999, pp. 1200-1209
Citations number
26
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
Journal title
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY
ISSN journal
10453873 → ACNP
Volume
10
Issue
9
Year of publication
1999
Pages
1200 - 1209
Database
ISI
SICI code
1045-3873(199909)10:9<1200:EOTIAD>2.0.ZU;2-P
Abstract
Implantable Atrial Defibrillator. Introduction: The purpose of our study wa s to evaluate the effect of repeated cardioversion with an implantable atri al defibrillator on the clinical outcome of patients with atrial fibrillati on. Methods and Results: The effects of the implantable atrial defibrillator on the total duration of atrial fibrillation, number of atrial fibrillation r ecurrences, and left atrial size were evaluated prospectively in 16 patient s with atrial fibrillation (13 men and 3 women; mean age 58 +/- 11 Sears). Seven patients had no cardiovascular disease, 5 patients had hypertension, 3 patients had coronary heart disease, and 1 patient had congenital heart d isease. Eight patients had paroxysmal atrial fibrillation for a mean durati on of 80 +/- 61 months, and eight patients had persistent atrial fibrillati on for a mean duration of 68 +/- 119 months. Except for one patient who rec eived digoxin throughout the study, all patients received the same Class I or III antiarrhythmic agent throughout the study. The implantable atrial de fibrillator successfully converted 50 (93%) of 54 spontaneous episodes of a trial fibrillation in 12 patients. During the initial 3 months of clinical follow-up, the atrial defibrillator documented 261 +/- 270 hours of atrial fibrillation compared with 126 +/- 172 hours (P = 0.01) during the subseque nt 3 months. The left atrial size decreased from 4.4 +/- 0.7 cm at the time of atrial defibrillator implantation to 4.1 +/- 0.6 cm (P = 0.02) 6 months later. The number of atrial fibrillation recurrences did not change. These findings were observed in the absence of changes in drug therapy. No compl ications were observed. Conclusion: Restoration and maintenance of sinus rhythm in patients with at rial fibrillation by repeated cardioversion,vith an implantable atrial defi brillator was associated with a reduction in the total arrhythmia duration and a reduction in left atrial size. These results suggest that maintenance of sinus rhythm with the atrial defibrillator may reverse the remodeling p rocess associated with atrial fibrillation.